CROSS-STANDARD public interest · PPE / respirator (mask)

China-to-US PPE Respirator & Mask Compliance Gap Matrix

AI-compiled from official public sources — cross-checked by multiple AI models, not human-verified. Informational only; see disclaimer. Public-interest, source-linked comparison of Chinese GB 2626 KN95 and medical mask documentation against US NIOSH 42 CFR Part 84 approval, FDA 510(k) clearance, OSHA 29 CFR 1910.134 workplace requirements, labelling obligations, and market-access prerequisites. Covers industrial respirators, surgical masks, and surgical N95s.

Dataset 2026-06-11 Last verified 2026-06-12 5 rows

GAP MATRIX

Compliance Gap Matrix

Gap matrix
Compliance item Common China baseline United States (NIOSH / FDA) Gap / action Source + verification date
Labelling and Marking Requirements — NIOSH Approval Markings and FDA Device Labelling In China, GB 2626-2019 requires respirator markings including: manufacturer name, product name, model, production date, production batch number, validity period, applicable standard number (GB 2626), and the filter class (KN90/KN95/KP95/KP100). Packaging must include inspection certificate and instructions. NMPA-registered medical masks follow additional NMPA labelling regulations. Chinese labelling conventions — particularly 'KN95' without a TC number — are not recognised as NIOSH-compliant in the US market and have been the subject of CBP import enforcement actions.GB 2626-2019 — Section 6: Marking requirements (SAMR)
YY 0469-2011 — Section 7: Marking (NMPA, medical surgical masks)		 NIOSH-approved respirators must bear specific markings per 42 CFR Part 84: (1) on the respirator facepiece — NIOSH logo, TC approval number (e.g., TC-84A-XXXX), filter class (N95/N99/P100), and approval holder name/model number; (2) on packaging — lot number, manufacturing date, shelf life if applicable, instructions for use, limitations and warnings (e.g., 'Not for use in atmospheres containing less than 19.5% oxygen'). For FDA-cleared surgical masks and surgical N95s, additional labelling is required per 21 CFR Part 801: intended use, directions for use, manufacturer name and address, and relevant special warnings. English-language labelling is required. Counterfeit or non-compliant markings (e.g., 'KN95' without a TC number, or unauthorised 'N95' claims) are subject to FTC/FDA enforcement.42 CFR Part 84 — NIOSH Approval Programme marking requirements
21 CFR Part 801 — Labeling (FDA medical device labelling requirements)
NIOSH: Standard Numbering System for NIOSH-Approved Respirators (TC-84A series)		 Key labelling gaps for Chinese manufacturers entering the US: (1) 'KN95' is a Chinese designation — it cannot appear as a filter class claim on a NIOSH-approved respirator; the correct marking is 'N95' only after TC approval. Selling a product marked 'KN95' as equivalent to N95 in the US constitutes a false claim subject to FTC and FDA action. (2) NIOSH TC number must appear on both the respirator and packaging — Chinese products without a TC number cannot lawfully represent themselves as NIOSH-approved. (3) Shelf-life and lot-number marking conventions differ; US requirements must be followed. (4) English-language instructions and warnings are mandatory for US market; Chinese-only labelling is non-compliant.[INFORMATIONAL] NIOSH-approved respirators must bear the TC number, NIOSH logo, and filter class on the facepiece and packaging. 'KN95' is a Chinese designation with no NIOSH equivalence — using it as an N95 equivalence claim in the US is a false representation subject to enforcement. FDA-cleared surgical masks and surgical N95s require additional English-language labelling under 21 CFR Part 801. Chinese labelling alone does not satisfy US requirements. CDC / NIOSH — National Personal Protective Technology Laboratory (NPPTL)2026-06-12 · unverified
Market Access — US Registration, US Agent, CBP Import, No CE Equivalence China has no equivalent 'US agent' or 'US-entity approval holder' requirement for domestic market access. Chinese domestic registration for respiratory PPE is handled through SAMR/CNCA (for GB 2626 industrial respirators) or NMPA (for medical masks). Export to the US requires navigating the NIOSH and FDA frameworks, which have no reciprocal pathway from the Chinese domestic certification system. Chinese manufacturers sometimes appoint US-based 'importers of record' for CBP purposes, but this is a customs role — it does not substitute for NIOSH approval or FDA establishment registration.SAMR/CNCA — GB 2626 industrial respirator certification framework
NMPA — Medical device registration (Class II) for YY 0469 surgical masks and GB 19083 medical protective masks		 To lawfully sell respirators and medical masks in the US market, a Chinese manufacturer must satisfy several market-access requirements: (1) NIOSH approval holder must be a US-registered entity for respirators — foreign manufacturers typically establish a US subsidiary or appoint a US-based approval holder. (2) For FDA-regulated surgical masks and surgical N95s, the foreign manufacturer must designate a US Agent (21 CFR Part 807.40) and complete FDA establishment registration prior to import. (3) US Customs and Border Protection (CBP) enforces import admissibility; products making unsubstantiated N95 claims or lacking NIOSH TC numbers are subject to detention or seizure. (4) No CE marking, no EU MDR/PPE Regulation approval, and no other foreign approval substitutes for NIOSH or FDA clearance. (5) There is no mutual recognition agreement (MRA) between the US and China for respiratory protective equipment or medical devices in this category.42 CFR Part 84 — NIOSH Approval Programme (approval holder entity requirements)
21 CFR Part 807 — Establishment Registration and Device Listing (FDA — US agent requirement at 807.40)
21 CFR Part 807 Subpart B — Procedures for Device Establishment Registration
CBP — Import Admissibility: FDA-regulated products (medical devices, respirators)		 Market access gaps are structural: (1) No MRA between US and China — every Chinese respirator requires fresh NIOSH approval or FDA 510(k) regardless of Chinese certifications held. (2) NIOSH approval holder must be US-registered — Chinese-only entities cannot hold approvals directly; a US legal presence or partnership is required. (3) FDA establishment registration and US agent designation are prerequisites for import of surgical masks and surgical N95s — without these, CBP can detain shipments at the border. (4) CE marking (EU PPE Regulation 2016/425 or EU MDR) provides no market access in the US and is not accepted by NIOSH or FDA. (5) COVID-era EUAs that allowed non-NIOSH-approved KN95 imports are expired; shipments relying on expired EUA authorisations are inadmissible.[INFORMATIONAL] There is no US-China MRA for respirators or medical masks. NIOSH approval requires a US-registered approval holder. FDA-regulated surgical masks and surgical N95s require FDA establishment registration and a US agent before import. CE marking and Chinese NMPA/CNCA certifications provide no US market access. COVID-era EUAs permitting KN95 imports are expired and no longer applicable. Any shipment relying on expired EUAs or making unsubstantiated N95/NIOSH claims is subject to CBP detention or seizure. U.S. Food and Drug Administration (FDA) — Device Registration and Listing2026-06-12 · unverified
OSHA Workplace Respirator Program — 29 CFR 1910.134 China's workplace respiratory protection is governed by GB/T 18664-2002 (Selection, use and maintenance of respiratory protective equipment) and employer obligations under the Work Safety Law (安全生产法) and Law on Prevention and Control of Occupational Diseases (职业病防治法). In China, certified GB 2626 KN95 respirators are mandated for workplaces with airborne particle hazards. Chinese employers do not conduct OSHA-style written programs or OSHA Appendix A fit testing; instead, they follow GB/T 18664 selection guidance and local safety supervision requirements from SAMR and local Work Safety Supervision Bureaus.GB/T 18664-2002 — Selection, use and maintenance of respiratory protective equipment (SAMR)
GB 2626-2019 — Non-powered air-purifying particle respirator (product standard)
PRC Work Safety Law (安全生产法, as amended 2021)
PRC Law on Prevention and Control of Occupational Diseases (职业病防治法, as amended 2018)		 OSHA 29 CFR 1910.134 (Respiratory Protection standard) governs the use of respirators in US workplaces. Key employer obligations include: (1) establishing a written respiratory protection program; (2) selecting NIOSH-approved respirators appropriate for the hazard; (3) conducting fit testing for tight-fitting facepieces (quantitative or qualitative per OSHA Appendix A); (4) medical evaluation of employees before respirator use; (5) training workers on proper use, donning/doffing, and limitations; (6) maintaining respirators in clean, sanitary condition. Only NIOSH-approved respirators (TC-numbered) may be used to satisfy OSHA 1910.134 respiratory protection requirements. Non-NIOSH-approved masks — including KN95 — do not satisfy OSHA compliance even if worn voluntarily.29 CFR 1910.134 — Respiratory Protection (OSHA General Industry Standard)
29 CFR 1926.103 — Respiratory Protection (OSHA Construction Standard)
NIOSH 42 CFR Part 84 — Approval of Respiratory Protective Devices (product approval prerequisite)		 For US workplace use, OSHA 1910.134 mandates NIOSH-approved respirators. The gap has two layers: (1) Product gap — KN95 respirators certified to GB 2626 are not NIOSH-approved and cannot be used to satisfy OSHA 1910.134 requirements in US workplaces; employers who specify KN95 for OSHA-regulated hazards are non-compliant. (2) Program gap — Chinese occupational safety programs (GB/T 18664) do not meet OSHA's written program, fit testing, and medical evaluation obligations. Chinese manufacturers exporting to US industrial buyers must ensure their products carry NIOSH TC approval numbers and are accompanied by documentation supporting OSHA-compliant fit testing.[INFORMATIONAL] OSHA 29 CFR 1910.134 mandates NIOSH-approved respirators for US workplace use. KN95 respirators certified under Chinese GB 2626 do not satisfy OSHA requirements. Chinese manufacturers targeting the US occupational market must obtain NIOSH 42 CFR Part 84 TC approval as a prerequisite; without it, their products cannot be specified by US employers for OSHA-regulated respiratory hazards. U.S. Occupational Safety and Health Administration (OSHA)2026-06-12 · unverified
Respirator Approval — NIOSH 42 CFR Part 84 China requires GB 2626-2019 (Respiratory protective equipment — Non-powered air-purifying particle respirator) for industrial/occupational KN95 respirators, administered by SAMR. Medical-grade masks follow GB 19083-2010 (Technical requirements for medical protective masks). GB 2626 KN95 means the filter meets 95% efficiency in Chinese test conditions (NaCl aerosol at 85 L/min). NIOSH and SAMR/CNCA have NO mutual recognition agreement — KN95 certification under GB 2626 is NOT equivalent to NIOSH N95 approval under 42 CFR Part 84 and is not accepted as such in the US market. COVID-era NIOSH Emergency Use Authorizations (EUAs) that temporarily permitted non-NIOSH-approved respirators have all expired.GB 2626-2019 — Respiratory protective equipment — Non-powered air-purifying particle respirator (SAMR)
GB 19083-2010 — Technical requirements for medical protective masks (NMPA/SAMR)		 All air-purifying particulate respirators (including N95, N99, N100, P100, R95 etc.) sold or used in the United States must be approved by NIOSH under 42 CFR Part 84. NIOSH tests filtration efficiency, exhalation resistance, inhalation resistance, and facepiece integrity. The approval holder must be a US-registered entity. Each approved model receives a TC (Type Certificate) number that must appear on the respirator and its packaging. N95 filters at least 95% of airborne particles; N99 at least 99%; N100 at least 99.97%; P100 at least 99.97% (oil-proof). Approval is product-specific — a change in design, materials, or manufacturing site requires a new or amended approval.42 CFR Part 84 — Approval of Respiratory Protective Devices (NIOSH/CDC)
NIOSH Approval Program — Particulate Filtering Facepiece Respirators		 The gap is fundamental and non-waivable: (1) KN95 (GB 2626) approval does NOT satisfy NIOSH 42 CFR Part 84 — there is no mutual recognition, no bridging pathway, and no equivalence ruling. A Chinese manufacturer must apply to NIOSH directly and undergo full NIOSH testing on each model. (2) The approval holder must be a US-registered entity — a Chinese company without a US presence cannot hold a NIOSH approval directly (a US-registered affiliate or agent is required). (3) COVID-era EUAs that once permitted KN95 imports are expired and no longer provide any market-access pathway. (4) Each distinct respirator model requires its own TC approval number — approval cannot be transferred or applied across model variants.[INFORMATIONAL] NIOSH approval under 42 CFR Part 84 is mandatory for particulate respirators in the US. Chinese GB 2626 KN95 certification is NOT equivalent and does not satisfy this requirement. No mutual recognition exists between NIOSH and Chinese certification authorities. COVID-era EUAs permitting KN95 imports have expired. Chinese manufacturers must apply to NIOSH directly, with a US-registered approval holder. U.S. Government Publishing Office — eCFR (Electronic Code of Federal Regulations)2026-06-12 · unverified
Medical / Surgical Mask Route — FDA 510(k) and Surgical N95 Dual Pathway China regulates medical masks under YY 0469-2011 (Medical surgical masks — Technical requirements) for surgical masks, and GB 19083-2010 (Technical requirements for medical protective masks) for medical-grade protective masks equivalent to the surgical N95 concept. These are administered by NMPA (National Medical Products Administration). YY 0469 covers filtration efficiency (BFE ≥95%), splash resistance, and breathability. NMPA registration (Class II medical device) is required for domestic sale. NMPA registration and YY 0469/GB 19083 certification are NOT accepted as equivalent to FDA 510(k) clearance — there is no US-China mutual recognition for medical device approval.YY 0469-2011 — Medical surgical masks — Technical requirements (NMPA)
GB 19083-2010 — Technical requirements for medical protective masks (NMPA/SAMR)		 FDA regulates surgical masks and surgical respirators as Class II medical devices under 21 CFR Part 878. A surgical mask (product code FPA) intended for use in surgical settings must obtain FDA 510(k) clearance demonstrating substantial equivalence to a predicate device, covering fluid resistance (ASTM F1862), flammability (16 CFR Part 1610), differential pressure (breathability), and bacterial filtration efficiency (BFE ≥98%). A surgical N95 respirator combines NIOSH 42 CFR Part 84 approval AND FDA 510(k) clearance — both are mandatory simultaneously. Manufacturers must also register their establishment with FDA (21 CFR Part 807) and list the device. Non-surgical (industrial/occupational) N95 respirators approved by NIOSH alone do NOT require FDA clearance but cannot be marketed for surgical use.21 CFR Part 878 — General and Plastic Surgery Devices (FDA — surgical mask classification)
21 CFR Part 807 — Establishment Registration and Device Listing (FDA)
ASTM F1862 — Standard Test Method for Resistance of Medical Face Masks to Penetration by Synthetic Blood
FDA Guidance: Surgical Masks — Premarket Notification [510(k)] Submissions		 Three distinct gaps exist depending on product type: (1) Surgical mask — must obtain FDA 510(k) clearance (separate from NIOSH); Chinese YY 0469 NMPA registration is not a substitute. (2) Surgical N95 — must obtain BOTH NIOSH 42 CFR Part 84 approval AND FDA 510(k) clearance; this dual pathway is unique to the US and has no equivalent in China. (3) Industrial/occupational N95 — NIOSH approval only required, no FDA clearance needed, but cannot be labelled or marketed for surgical use. FDA establishment registration (US agent required for foreign manufacturers) is mandatory for all medical mask types regardless of 510(k) status.[INFORMATIONAL] Surgical masks require FDA 510(k) clearance as Class II medical devices. Surgical N95 respirators require both NIOSH 42 CFR Part 84 approval and FDA 510(k) clearance simultaneously. Chinese NMPA registration under YY 0469 or GB 19083 is not equivalent and does not satisfy FDA requirements. Foreign manufacturers must appoint a US agent and complete FDA establishment registration before export. U.S. Food and Drug Administration (FDA)2026-06-12 · unverified

E-E-A-T

Named editorial review

Pending named reviewer

Official regulator, standards body, notified body, customs, or primary legal source preferred. Local PDFs are not accepted.

Editorial controls

Rows must include publisher, official URL, access date, verification flag, and last_verified before human_reviewed can be true.

SOURCES

Official-source register.